Since gene regulatory networks provide a systematic view of a complex living system, it is important to develop tools which are not only able to build reliable and large-scale gene regulatory networks but also able to identify disease candidate genes using the estimated networks. In this work, we introduce a reverse engineering technique, Bayesian model averaging based networks (BMAnet), which ensembles all appropriate linear models to tackle the uncertainty of model selection and integrates heterogeneous biological datasets. Then various network evaluation measures are used for the comparison of estimated networks and one of the measures called random walk with restart (Rwr) is utilized to search for disease candidate genes.
be linked to each other as a module (motif) in the sparse and large-scale GRNs Burda et al. (2011 ), Milo et al. (2002 , Berg & Lässig (2004) ). So number of graph alignment techniques based on graph theory have been introduced Flannick et al. (2006) , Berg & Lässig (2006) , Kuchaiev et al. (2010) , Xulvi-Brunet & Li (2010) along with structural measurements Barabási & Oltvai (2004) .
The aim of our study is to find disease candidate genes using large-scale GRNs estimated from various source of biological information including mRNA expression. To this end, we introduce a reverse engineering technique based on Bayesian model averaging (BMA) technique Raftery (1995) which ensembles all appropriate linear models to tackle the uncertainty of model selection and integrate heterogeneous biological datasets using Gibbs prior distribution Imoto et al. (2002) , Werhli & Husmeier (2008) . Then the estimated networks are evaluated using 10 different quantities and one of the quantities called "random walk with restart" is utilized to identify the disease candidate genes by measuring the distances from a gene to a set of genes that are known to be related with the target disease.
Bayesian model average for large-scale GRNs
The basic idea of our GRN construction is to search for every possible linear models with a fixed in-degree k and aggregate appropriate models using BMA. Suppose a standardized gene expression dataset X = x 1 , ..., x p where x i indicates the ith gene then we can define a regression model (denoted by M il ) with k genes
where S lk represents a set of genes belonging to lth combination among all possible combinations each of which consists of k genes, b ji is a coefficient representing the effect of the jth gene on the ith gene, and e i is an error term. For example, when X = {x 1 , x 2 , x 3 , x 4 }, k = 2 and i = 1, all possible combinations of the independent variables (j = 2, 3, 4) are S 12 = {x 2 , x 3 }, S 22 = {x 2 , x 4 }, and S 32 = {x 3 , x 4 }. So M 11 is x 1 = b 21 x 2 + b 32 x 3 + e 1 . Let θ ji be the true coefficient of b ji . Then our aim is to find p(Θ|X) where Θ = (θ 1 , ..., θ i ) and , ..., p}) . By Bayes' rule and the law of total probability,
where
and L is the number of all possible models. These equations mean that the full posterior distribution of θ ji is a weighted average of its posterior distributions, p(θ ji |X, M il ) and the weight is the posterior model probability, p(M il |X). Raftery obtained the posterior model probability approximation which is called Bayesian information criteria (BIC) Raftery (1995) . BIC of M il is n log(1 − R 2 ) + k log n where R 2 is the coefficient of determination of the model M il . In our study, maximum k value is fixed three for computation efficiency so, in an exhaustive searching, total number of models
. Now, we can obtain the posterior mean approximation of the true coefficient as follows Raftery (1995) 
where I(C) is an indicator function which is 1 when C is true or 0 other wise. In order to reduce false positives, we can prune the edges whose effect size is likely to be zero by deleting the edges having the smallest value of Equation (4) until its edge rato in Equation (5) reaches a criterion α Er .
Note that, in our real data example, we use α Er = 0.002 which is in agreement with Er ≈ 0.002 observed in DNA-protein/protein-protein networks from BIOGRID Stark et al. (2006) . In order to integrate heterogeneous data and enhance the biological meaning of the estimated GRNs, we used the model prior, p(M il ), having the form of Gibbs distribution which was successfully applied in other integration studies Imoto et al. (2002) , Werhli & Husmeier (2008) . Assume a set of genes V i affects the ith gene, which is known from other sources of biological data. Then we can define an 'energy' function of M il as follows.
where I is an indicator function and k is the number of in-degrees. The meaning of this energy is a gap between observed and expected degrees that the model M il is true. Equation (6) explains that the energy is zero when the dependent variables of the model M il are all appeared in V i while it increases as no evidences are found in the source. In this way, other biological information can also be taken to enhance the biological significance of the inferred GRNs. If we have two energy functions, E 1 and E 2 , from different sources, then the prior distribution will be
where G is a normalization constant and β 1 and β 2 are hyperparameters which indicates the strength of the influence of the prior knowledge. In our study, β 1 = β 2 = 5 based on the simulation study but Werhli et. al. showed appropriate values could be chosen automatically Werhli & Husmeier (2008) .
Network Evaluation
A network structure estimated by reverse engineering methods has been commonly evaluated in terms of sensitivity and specificity by comparing it to a reference network structure. But we used following 10 measures (In Figure 1) including (a) total number of edges and (b) maximum degree of a network graph.
(c) Difference of degree (Dd): The degree of a node means the number of connections to the other nodes. Let d g (i) be the degree of the ith gene in a network structure (Sens), (e) specificity (Spec), and (f) positive predictive value (Ppv) are defined as fallows,
where T P , F P , F N , and T N are the number of true positive, false positive, false negative, and true negative, respectively.
(g) Similarity (Sim): It measures the similarity of two networks, A and B. Let E g be the set of edges of a network structure g (g = {A, B}) then Sim can be defined
where N (S) indicates the number of elements of a set S. Sim has the value 1 when both networks are the same, and decreases as two networks share less edges Xulvi-Brunet & Li (2010).
(h) Clustering coefficient (Cc): (Global) Clustering coefficient is a ratio between the number of connections existing among three nodes in its neighbering triplet structure and the maximal number of edges that can exist among them. If we denote the clustering coefficient of the ith node in a network g by C g (i) then Cc can be defined as
(i) Average shortest path length (Asp): Shortest path length is the number of edges between two nodes in a (undirected) network so Asp is the mean distance of two nodes when these two are reachable.
where l(i, j) is the shortest length between two nodes, i, j(= 1, 2, ..., n). l(i, j) = 0 when i = j or the i node cannot reach to the jth node.
(j) Random walk with restart (Rwr): Random walk on an undirected graph can be used to capture the relationship of a group of nodes in the given network structure Köhler et al. (2008) . As a variant of the discrete-time random walk process, random walk with restart allows the walk to start again from the initial node s with probability r in every time step. Let p t be a length n vector where the ith element is the probability that the walker is at node i at time t. Then the next probability of Rwr is defined as follows.
where A is the column-normalized adjacency matrix of the graph and p 0 is the initial probability vector which includes a set of non-zero elements (a group of genes that we are interested in, denoted by Z). The steady state probability vector of p t can be obtained by iterating Equation (15) until the difference between p t and p t+1 is less than a criterion (10 −6 in this study). Therefore, the Rwr of the group of genes is
where Z is the set of genes which are known to be related to a target disease.
Disease Candidate Gene Detection
Conventionally, disease candidate genes have been found using differentially expressed gene (DEG) approaches such as t-test or ANOVA. But in this research, we search for the candidate genes that closely linked to a group of disease related genes by measuring the distance from the group of genes to the candidate gene. Given the set of genes Z which are disease related genes, the distance between Z and the ith gene (Rwr i ) can be defined as
where Z ′ = {Z, i} and p j is the jth element of vector p. This Rwr has high value if the genes in Z are closely connected to the target gene i. Note that as an alternative of Rwr, Asp in Equation (14) could be used as a similarity measure among a group of genes but it is known that Rwr outperforms Asp which does not consider the topology of the group members Köhler et al. (2008) .
Simulation study
To evaluate the proposed Bayesian model averaging network (BMAnet), we generated large-scale gene expression data as follows. Firstly large-scale networks whose in-degree distribution follows scale-free Barabási & Oltvai (2004) was obtained using R package "igraph". Each of these network structures was converted into a covariance matrix Geiger & Heckerman (1994) with appropriate edge weights which were randomly chosen among {−2, −1, −0.5, 0.5, 1, 2}. Then the expression data were generated from the multivariate normal distribution using R package "mvtnorm". In this way, we prepared 40 datasets consisting of 20 replications for 1000 and 2000 nodes, respectively. Each dataset has 50 samples. We used these simulated datasets to estimate their network structure using three reverse engineering methods, BMAnet, elastic-net (Enet) Zou & Hastie (2005) and Gaussian graphical model with shrinkage estimator (GGM) Opgen-Rhein & Strimmer (2007a) . In addition to the 8 quantities described in Method section, two more quantities, the number of edges and max degree, were measured from the inferred networks.
On the other hand, in order to evaluate Rwr used to detect disease candidate genes, we inserted a module network consisting of 10 nodes into each simulated network structure. A node in the module network is reachable directly or indirectly to any of the other 9 nodes. These 10 nodes are considered as the disease related genes (Z in Equation (17)). So high Rwr means that a walker tends to be stay in any of the 10 nodes with a high probability, which reflects the 10 nodes are closely linked together. Figure 1 shows the mean and standard deviation of the 10 quantities including the total number of edges and max degrees in each of 1000 and 2000 node datasets. Note that we fixed the specificity by 0.99 in estimating network structures. In Figure 1 , (a) the total number of edges shows similar amongst the three methods but is getting larger as the number of node increases despite the tight control of specificity (0.99). (b) The max degrees of the true network structures reached around 300 to 400 with large variances. Though BMAnet limited the maximum in-degree of a model by three, its estimated network structures have more than 50 degrees, which is almost the same as Enet. (c) In the difference of degrees, Enet shows the most closest to the true networks. However, BMAnet has the best performance in terms of (d) sensitivity, (f) positive predictive value and (g) similarity. (h) The clustering coefficient of BMAnet is also the most similar to that of true networks. (i) Average shortest path values of BMAnet and Enet are comparable to that of the true networks. But variance of BMAnet is smaller than the others. (j) Random walk with restart (The higher, the better) of BMAnet is relatively lower than Enet and GGM but BMAnet shows the most robust results.
Human Brain tumor GRNs
In order to apply our approach to real data, human brain tumor dataset GSE4290 was collected from Gene Expression Omnibus (GEO) and its large-scale GRNs were constructed. This dataset has total 107 samples which consist of 23 nontumor, 76 grade III tumor (26 astrocytomas + 50 oligodendrogliomas), and 81 grade IV tumor (glioblastomas) samples. We normalized the expression data of each grade and selected 4422 genes based on the significant DEGs from ANOVA. Then BMAnet was applied to build the network structures for each of the three groups. Note that the samples of this dataset were not measured in time course, the estimated networks are more likely to be "co-expression networks" rather than "gene regulatory networks". Along with the expression datasets, DNA-protein binding affinity Ernst et al. (2010) is used to update the prior information of BMAnet. Figure 2 shows the in/out-degree distributions of the estimated networks. Though the distributions are not exactly following the power-law distribution, they show a reasonable range of in/out-degrees covering more than 20 (e 3 ) despite a model in BMAnet has the maximum three in-degree limitations.
In order to find candidate genes affecting brain tumor, we found 107 tumor related genes from NCBI Gene database. Then the Rwr i of Equation (17) were measured for all 4422 genes and identified 169 genes that are up-regulated in grade III and IV samples while they are not expressed in non-tumor samples. In Figure ( 3), (d), (e) and (f) show the non-tumor, grade III, and grade IV gene networks, respectively. Light gray dots indicate the known 107 tumor related genes and dark gray ones denote the identified 169 genes via our approach. As we expected, the 169 genes are more closely linked with the known 107 genes in the grade III and IV networks than the non-tumor network. In order to estimate the functional properties of these 169 genes, we obtained the over-represented GO terms of these genes using DAVID Da Wei Huang et al. (2008) which performs Fisher exact test for evaluating the association between two independent groups (observed proportion in a group vs. background proportion in the other group). Table 1 shows GO terms whose p-values of the Exact test are less than an empirically chosen criterion (0.1). It shows that many of the 169 genes are related with regulations of "wounding", "cell death", "cell cycle", and "apoptosis".
Discussion
In this study, we showed a series of large-scale gene network analyses that cover network construction, network evaluation, and disease candidate gene detection. BMA technique used in our approach has been usually employed to take into account the uncertainty of the model selection problem. So it could be one of the best solutions for explaining complex GRNs where their genes/proteins can alternatively interact with each other depending on their environmental conditions. Moreover, this Bayesian approach enables us to integrate different source of biological information such as the protein-DNA binding affinity. In order to evaluate the estimated networks, 10 quantities of the networks were compared using three different reverse engineering methods where BMAnet showed better or similar performance among the three methods. Finally, the disease candidate genes were found by one of the network evaluation measures, Rwr i , which is a distance from the ith gene to a group of genes known to be related with the target disease. Utilizing Rwr is not a new approach but we hope we can identify more reliable candidate genes by cooperating with a proper large-scale reverse engineering method. For example, in the brain tumor analysis, ANOVA and FDR adjustment detected too many DEGs (For example, 3023 out of 4422 genes have less FDR values than 0.01. These genes are indicated with black colored edges in Figure 3 (d) , (e), and (f)) so it is not possible to pick up proper candidates without the estimated network structures. Via further investigation of the candidate genes, we might be able to identify the disease triggering pathways which will provide more variety of drug targets in industry. But it is also necessary to understand more detailed regulatory relationships among the candidate genes including their proteins/metabolites' dynamic behaviors.
